(TSLX) Sixth Street Specialty - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US83012A1097
Stock: Senior Loans, Mezzanine Debt, Equity, Structured Products, Bonds
Total Rating 26
Risk 60
Buy Signal -0.75
| Risk 5d forecast | |
|---|---|
| Volatility | 28.6% |
| Relative Tail Risk | 0.23% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.51 |
| Alpha | -22.68 |
| Character TTM | |
|---|---|
| Beta | 0.546 |
| Beta Downside | 0.742 |
| Drawdowns 3y | |
|---|---|
| Max DD | 27.94% |
| CAGR/Max DD | 0.46 |
EPS (Earnings per Share)
Revenue
Description: TSLX Sixth Street Specialty March 01, 2026
Sixth Street Specialty Lending, Inc. (NYSE: TSLX) is a Business Development Company that originates and manages a diversified portfolio of senior secured, unsecured and mezzanine loans, as well as corporate bonds, equity securities and structured products, primarily targeting U.S. middle-market companies with enterprise values of $50 M-$1 B and EBITDA of $10 M-$250 M.
Its investment universe spans business services, software & technology, healthcare, energy, consumer & retail, manufacturing, industrials, royalty-related businesses, education and specialty finance. Transaction sizes range from $15 M to $350 M, and the firm can arrange syndicated deals up to $500 M, allowing it to hold sizable positions across the capital structure.
As of the latest quarter (Q4 2023), TSLX reported a net asset value of $1.42 B, a weighted-average loan yield of 8.3% and a dividend yield of roughly 6.1%, reflecting the premium pricing of middle-market credit in a rising-rate environment. The fund’s performance has been bolstered by a 4.2% YoY increase in loan origination volume, driven by strong demand for flexible financing amid ongoing corporate refinancing activity and a resilient U.S. economic outlook.
For a deeper dive into TSLX’s valuation metrics and risk profile, consider exploring the analysis on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 170.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -1.49 > 1.0 |
| NWC/Revenue: -68.35% < 20% (prev -7.98%; Δ -60.37% < -1%) |
| CFO/TA 0.04 > 3% & CFO 127.9m > Net Income 170.5m |
| Net Debt (1.72b) to EBITDA (230.8m): 7.47 < 3 |
| Current Ratio: 0.18 > 1.5 & < 3 |
| Outstanding Shares: last quarter (94.7m) vs 12m ago 2.35% < -2% |
| Gross Margin: 72.84% > 18% (prev 0.70%; Δ 7214 % > 0.5%) |
| Asset Turnover: 10.29% > 50% (prev 10.04%; Δ 0.24% > 0%) |
| Interest Coverage Ratio: 1.83 > 6 (EBITDA TTM 230.8m / Interest Expense TTM 105.6m) |
Altman Z'' 0.02
| A: -0.07 (Total Current Assets 53.8m - Total Current Liabilities 300.0m) / Total Assets 3.42b |
| B: 0.02 (Retained Earnings 81.6m / Total Assets 3.42b) |
| C: 0.06 (EBIT TTM 192.9m / Avg Total Assets 3.50b) |
| D: 0.05 (Book Value of Equity 82.6m / Total Liabilities 1.81b) |
| Altman-Z'' Score: 0.02 = B |
Beneish M
| DSRI: 1.12 (Receivables 34.1m/30.5m, Revenue 360.2m/359.7m) |
| GMI: 0.97 (GM 72.84% / 70.32%) |
| AQI: none (AQ_t none / AQ_t-1 none) |
| SGI: 1.00 (Revenue 360.2m / 359.7m) |
| TATA: 0.01 (NI 170.5m - CFO 127.9m) / TA 3.42b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of TSLX shares?
As of March 07, 2026, the stock is trading at USD 18.33 with a total of 1,396,705 shares traded.
Over the past week, the price has changed by +5.83%, over one month by -9.07%, over three months by -16.16% and over the past year by -9.96%.
Over the past week, the price has changed by +5.83%, over one month by -9.07%, over three months by -16.16% and over the past year by -9.96%.
Is TSLX a buy, sell or hold?
Sixth Street Specialty has received a consensus analysts rating of 4.36.
Therefore, it is recommended to buy TSLX.
- StrongBuy: 5
- Buy: 5
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the TSLX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 22.5 | 22.5% |
| Analysts Target Price | 22.5 | 22.5% |
TSLX Fundamental Data Overview March 03, 2026
P/E Trailing = 9.5691
P/E Forward = 8.9047
P/S = 3.6528
P/B = 1.0203
P/EG = 1.2745
Revenue TTM = 360.2m USD
EBIT TTM = 192.9m USD
EBITDA TTM = 230.8m USD
Long Term Debt = 1.44b USD (estimated: total debt 1.74b - short term 300.0m)
Short Term Debt = 300.0m USD (from shortTermDebt, last quarter)
Debt = 1.74b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.72b USD (from netDebt column, last quarter)
Enterprise Value = 3.36b USD (1.64b + Debt 1.74b - CCE 19.7m)
Interest Coverage Ratio = 1.83 (Ebit TTM 192.9m / Interest Expense TTM 105.6m)
EV/FCF = 26.30x (Enterprise Value 3.36b / FCF TTM 127.9m)
FCF Yield = 3.80% (FCF TTM 127.9m / Enterprise Value 3.36b)
FCF Margin = 35.51% (FCF TTM 127.9m / Revenue TTM 360.2m)
Net Margin = 47.34% (Net Income TTM 170.5m / Revenue TTM 360.2m)
Gross Margin = 72.84% ((Revenue TTM 360.2m - Cost of Revenue TTM 97.8m) / Revenue TTM)
Gross Margin QoQ = 76.83% (prev 70.57%)
Tobins Q-Ratio = 0.98 (Enterprise Value 3.36b / Total Assets 3.42b)
Interest Expense / Debt = 1.61% (Interest Expense 28.0m / Debt 1.74b)
Taxrate = 4.44% (1.39m / 31.4m)
NOPAT = 184.3m (EBIT 192.9m * (1 - 4.44%))
Current Ratio = 0.18 (Total Current Assets 53.8m / Total Current Liabilities 300.0m)
Debt / Equity = 1.08 (Debt 1.74b / totalStockholderEquity, last quarter 1.61b)
Debt / EBITDA = 7.47 (Net Debt 1.72b / EBITDA 230.8m)
Debt / FCF = 13.47 (Net Debt 1.72b / FCF TTM 127.9m)
Total Stockholder Equity = 1.61b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.87% (Net Income 170.5m / Total Assets 3.42b)
RoE = 10.58% (Net Income TTM 170.5m / Total Stockholder Equity 1.61b)
RoCE = 6.31% (EBIT 192.9m / Capital Employed (Equity 1.61b + L.T.Debt 1.44b))
RoIC = 5.42% (NOPAT 184.3m / Invested Capital 3.40b)
WACC = 4.63% (E(1.64b)/V(3.38b) * Re(7.93%) + D(1.74b)/V(3.38b) * Rd(1.61%) * (1-Tc(0.04)))
Discount Rate = 7.93% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 3.84%
[DCF] Terminal Value 80.82% ; FCFF base≈151.6m ; Y1≈99.5m ; Y5≈45.4m
[DCF] Fair Price = N/A (negative equity: EV 1.45b - Net Debt 1.72b = -276.4m; debt exceeds intrinsic value)
EPS Correlation: 53.05 | EPS CAGR: 6.52% | SUE: 4.0 | # QB: 1
Revenue Correlation: 42.22 | Revenue CAGR: 15.35% | SUE: -2.31 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.50 | Chg7d=-0.002 | Chg30d=-0.006 | Revisions Net=-3 | Analysts=9
EPS current Year (2026-12-31): EPS=1.98 | Chg7d=-0.003 | Chg30d=-0.023 | Revisions Net=-3 | Growth EPS=-14.9% | Growth Revenue=-8.5%
EPS next Year (2027-12-31): EPS=1.96 | Chg7d=+0.051 | Chg30d=+0.028 | Revisions Net=+0 | Growth EPS=-1.3% | Growth Revenue=+0.6%
[Analyst] Revisions Ratio: -0.60 (1 Up / 4 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -2.5% (Discount Rate 7.9% - Earnings Yield 10.5%)
[Growth] Growth Spread = -7.2% (Analyst -9.7% - Implied -2.5%)
P/E Forward = 8.9047
P/S = 3.6528
P/B = 1.0203
P/EG = 1.2745
Revenue TTM = 360.2m USD
EBIT TTM = 192.9m USD
EBITDA TTM = 230.8m USD
Long Term Debt = 1.44b USD (estimated: total debt 1.74b - short term 300.0m)
Short Term Debt = 300.0m USD (from shortTermDebt, last quarter)
Debt = 1.74b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.72b USD (from netDebt column, last quarter)
Enterprise Value = 3.36b USD (1.64b + Debt 1.74b - CCE 19.7m)
Interest Coverage Ratio = 1.83 (Ebit TTM 192.9m / Interest Expense TTM 105.6m)
EV/FCF = 26.30x (Enterprise Value 3.36b / FCF TTM 127.9m)
FCF Yield = 3.80% (FCF TTM 127.9m / Enterprise Value 3.36b)
FCF Margin = 35.51% (FCF TTM 127.9m / Revenue TTM 360.2m)
Net Margin = 47.34% (Net Income TTM 170.5m / Revenue TTM 360.2m)
Gross Margin = 72.84% ((Revenue TTM 360.2m - Cost of Revenue TTM 97.8m) / Revenue TTM)
Gross Margin QoQ = 76.83% (prev 70.57%)
Tobins Q-Ratio = 0.98 (Enterprise Value 3.36b / Total Assets 3.42b)
Interest Expense / Debt = 1.61% (Interest Expense 28.0m / Debt 1.74b)
Taxrate = 4.44% (1.39m / 31.4m)
NOPAT = 184.3m (EBIT 192.9m * (1 - 4.44%))
Current Ratio = 0.18 (Total Current Assets 53.8m / Total Current Liabilities 300.0m)
Debt / Equity = 1.08 (Debt 1.74b / totalStockholderEquity, last quarter 1.61b)
Debt / EBITDA = 7.47 (Net Debt 1.72b / EBITDA 230.8m)
Debt / FCF = 13.47 (Net Debt 1.72b / FCF TTM 127.9m)
Total Stockholder Equity = 1.61b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.87% (Net Income 170.5m / Total Assets 3.42b)
RoE = 10.58% (Net Income TTM 170.5m / Total Stockholder Equity 1.61b)
RoCE = 6.31% (EBIT 192.9m / Capital Employed (Equity 1.61b + L.T.Debt 1.44b))
RoIC = 5.42% (NOPAT 184.3m / Invested Capital 3.40b)
WACC = 4.63% (E(1.64b)/V(3.38b) * Re(7.93%) + D(1.74b)/V(3.38b) * Rd(1.61%) * (1-Tc(0.04)))
Discount Rate = 7.93% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 3.84%
[DCF] Terminal Value 80.82% ; FCFF base≈151.6m ; Y1≈99.5m ; Y5≈45.4m
[DCF] Fair Price = N/A (negative equity: EV 1.45b - Net Debt 1.72b = -276.4m; debt exceeds intrinsic value)
EPS Correlation: 53.05 | EPS CAGR: 6.52% | SUE: 4.0 | # QB: 1
Revenue Correlation: 42.22 | Revenue CAGR: 15.35% | SUE: -2.31 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.50 | Chg7d=-0.002 | Chg30d=-0.006 | Revisions Net=-3 | Analysts=9
EPS current Year (2026-12-31): EPS=1.98 | Chg7d=-0.003 | Chg30d=-0.023 | Revisions Net=-3 | Growth EPS=-14.9% | Growth Revenue=-8.5%
EPS next Year (2027-12-31): EPS=1.96 | Chg7d=+0.051 | Chg30d=+0.028 | Revisions Net=+0 | Growth EPS=-1.3% | Growth Revenue=+0.6%
[Analyst] Revisions Ratio: -0.60 (1 Up / 4 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -2.5% (Discount Rate 7.9% - Earnings Yield 10.5%)
[Growth] Growth Spread = -7.2% (Analyst -9.7% - Implied -2.5%)